Some Covid-19 trial sponsors never posted other study results in an EU database. Will they hide data again?
Amid a wave of research into potential Covid-19 therapies, a new analysis warns that some trials are being run by universities and companies in Europe that either have no track record filing any trial results with a European database or have failed to do so in the past. As a result, there is a risk that past performance might undermine the ongoing search for safe and effective treatments, according to the advocacy group that conducted the analysis.
Specifically, two-thirds of the 118 Covid-19 trials analyzed are currently run by universities and companies that have no record of uploading clinical study results to the European Union Drug Regulating Authorities Clinical Trials Database, or EudraCT, which trial sponsors are required to do so under EU rules. Of these, 39 trials are being run by sponsors that, in the past, violated requirements to upload results.
